Evidence map›Paper›PMID 36301086›Full record

ArticleMicrobial genomics2022

Epidemiological links and antimicrobial resistance of clinical

Michael Biggel, Jule Horlbog, Magdalena Nüesch-Inderbinen, Marie Anne Chattaway, Roger Stephan

Abstract read
In one paragraph

Article in Microbial genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. A commercial bacteriophage cocktail failed to decolonize Zophobas morio larvae and promoted overgrowth of an OXA-48-producing Salmonella enterica.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Article
  4. The emergence of chromosomally locatedFrontiers in microbiology · 2026
    Article
  5. One Health Investigation of a HouseholdPathogens (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Antibiotic-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  9. A novel variant inMicrobiology spectrum · 2024
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael BiggelInstitute for Food Safety and Hygiene, Vetsuisse Faculty University of Zürich, Zürich, Switzerland.
Jule HorlbogInstitute for Food Safety and Hygiene, Vetsuisse Faculty University of Zürich, Zürich, Switzerland.
Magdalena Nüesch-InderbinenInstitute for Food Safety and Hygiene, Vetsuisse Faculty University of Zürich, Zürich, Switzerland.
Marie Anne ChattawayGastrointestinal Bacteria Reference Unit, UK Health Security Agency, London, UK.
Roger StephanInstitute for Food Safety and Hygiene, Vetsuisse Faculty University of Zürich, Zürich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Infective AgentsSalmonella entericaAnti-Bacterial AgentsCiprofloxacinDrug Resistance, BacterialDrug Resistance, Multiple, BacterialGenomicsHumansMetagenomicsMicrobial Sensitivity TestsSwitzerlandAnti-Bacterial AgentsAnti-Infective AgentsCiprofloxacinciprofloxacin resistancegenomicspopulation structureprolonged Salmonella carriageramRSalmonella enterica Kentucky ST198

Identifiers

PMID36301086
PMCPMC9676052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.